SCHEMBL38659906

SCHEMBL38659906

Cc1cc(-c2ccc(O)cc2CCC(=O)O)ccc1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A3 P43003 2/20 0.47
▸ SLC1A2 P43004 2/20 0.47
▸ SLC1A1 P43005 2/20 0.47
▸ PTGDR2 Q9Y5Y4 2/20 0.47
▸ FFAR4 Q5NUL3 3/20 0.45
▸ RXRA P19793 2/20 0.43
▸ RXRB P28702 2/20 0.43
▸ RXRG P48443 2/20 0.43
▸ PTGER1 P34995 2/20 0.43
▸ PTGER4 P35408 2/20 0.43
▸ PTGER3 P43115 2/20 0.43
▸ PTGER2 P43116 2/20 0.43
▸ CTSK P43235 1/20 0.43
▸ FFAR1 O14842 4/20 0.42
▸ AKR1C3 P42330 1/20 0.42
▸ AKR1C2 P52895 1/20 0.42
▸ MME P08473 1/20 0.41
▸ MCL1 Q07820 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ PTGS2 P35354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1893748 1.00 SLC1A3 (0.47) SLC1A3SLC1A2SLC1A1PTGDR2FFAR4
SCHEMBL38659563 0.88 RXRA (0.44) PTGDR2FFAR4RXRARXRBRXRG
SCHEMBL1891430 0.88 RXRA (0.44) PTGDR2FFAR4RXRARXRBRXRG
SCHEMBL1896247 0.88 RXRA (0.44) PTGDR2FFAR4RXRARXRBRXRG
SCHEMBL38660151 0.88 KDM4E (0.46) SLC1A3SLC1A2SLC1A1PTGDR2MCL1
SCHEMBL1887566 0.88 KDM4E (0.46) SLC1A3SLC1A2SLC1A1PTGDR2MCL1
SCHEMBL1809637 0.86 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1PTGDR2FFAR4
SCHEMBL15959119 0.86 ESR2 (0.56) FFAR4PTGER1PTGER4PTGER3PTGER2
SCHEMBL1892708 0.85 FFAR1 (0.52) FFAR4RXRARXRBRXRGPTGER1
SCHEMBL1890265 0.85 MME (0.42) PTGDR2FFAR4RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026099533-A1 TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH GPBP1 INHIBITORS UNIVERSITAT DE VALÈNCIA (ES) 2026-05-15 — — WO claimed
WO-2026099533-A1 TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH GPBP1 INHIBITORS UNIVERSITAT DE VALÈNCIA (ES) 2026-05-15 — — WO disclosed
Send feedback